DOI QR코드

DOI QR Code

Maximum Tolerated Dose Estimate by Curve Fitting in Phase I Clinical Trial

제1상 임상시험에서 곡선적합을 이용한 MTD 추정법

Heo, Eun-Ha;Kim, Dong-Jae
허은하;김동재

  • Received : 20100900
  • Accepted : 20111100
  • Published : 2011.03.31

Abstract

The purpose of a Phase I clinical trial is to estimate the maximum tolerated dose, MTD, of a new drug. In this paper, the MTD estimation method is suggested by curve fitting the dose-toxicity data to an S-shaped curve. The suggested MTD estimation method is compared with established MTD estimation procedures using a Monte Carlo simulation study.

Keywords

Phase I clinical trial;Maximum tolerated dose(MTD);dose-toxicity curve

References

  1. 강승호 (2002). 1상 임상실험에서 수정된 CRM에 대한 연구, <응용통계연구>, 15, 323–336. https://doi.org/10.5351/KJAS.2002.15.2.323
  2. 김동욱, 길순경 (2009). 제 1상 임상시험의 SM, CRM, ATD에서 결정된 MTD의 정확성과 안전성비교, <한국통계학회 논문집>, 16, 51–65. https://doi.org/10.5351/CKSS.2009.16.1.051
  3. 박인혜 (1999). <제 1상 축차 임상시험의 최대 허용용량 추정법>, 가톨릭대학교 의학통계학과 의학통계전공 석사논문.
  4. Chevret, S. (1993). The continual reassessment method in cancer phase I clinical trials: A simulation study, Statistics in Medicine, 12, 1093–1108.
  5. Dixon, W. J. and Mode, A. M. (1948). A method for obtaining and analyzing sensitivity data, Journal of the American Statistical Association, 43, 109–126.
  6. Faries, D. (1994). Practical modifications of the continual reassessment method for phase I cancer clinical trials, Journal of Biopharmaceutical Statistics, 4, 147–164. https://doi.org/10.1080/10543409408835079
  7. Goodman, S. N., Zhurak, M. L. and Piantadosi, S. (1995). Some practical improvements in the continual reassessment method for phase I studies, Statistics in Medicine, 14, 1149–1161. https://doi.org/10.1002/sim.4780141102
  8. Johns, H. and Joiner, M. C. (1991). A simple method for fitting curves to dose-effect data for functional damage, International Journal of Radiation Biology, 60, 533–541.
  9. Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C. and Simon, R. M. (1994). A comparison of two phase I trial designs, Statistics in Medicine, 13, 1799–1806. https://doi.org/10.1002/sim.4780131802
  10. O’Quigley, J. and Chevret, S. (1991). Method for dose finding studies in cancer clinical trials: A review and results of a monte carlo study, Statistics in Medicine, 10, 1647-16641093-1108. https://doi.org/10.1002/sim.4780101104
  11. Storer, B. E. (1989). Design and analysis of phase I clinical trials, Biometrics, 45, 925–937. https://doi.org/10.2307/2531693